LOUISVILLE, Ky. (WAVE) - UPS Healthcare and Exact Sciences have been shipping at-home ‘Cologuard’ test kits for the last decade. WAVE News talked with both companies Tuesday. They say their ...

According to Exact Sciences, Cologuard has become an essential part of healthcare providers’ screening tool kit partly because of patients’ preferences and demands. The adoption of the test is ...

Exact Sciences (EXAS) stock rises as company announces release of data for blood-based cancer test on August 16. Read more ...

Cologuard has gone bilingual. The popular mail-in colorectal cancer screening test from Exact Sciences has a new campaign out ...

Exact Sciences EXAS continues to make significant progress with its Cologuard test and efforts to expand Oncotype DX overseas. Advancements in the key pipeline programs are highly promising.

New modelling data from diagnostics company Exact Sciences indicates that its Cologuard test for colorectal cancer (CRC) screening has detected almost 600,000 cases since receiving US Food and ...

So, when Kam’s doctor offered her a screening option that can be done at home, the Cologuard® test ... has provided consulting services for Exact Sciences. She has not been compensated for ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue ...

In terms of liquidity and interest, the mean open interest for Exact Sciences options trades today is 1016.57 with a total ...

Exact Sciences (EXAS) identifies more than 100 opportunities with payers and health systems to address the care gaps with Cologuard through screening programs. Exact Sciences (EXAS) initiates the ...

Exact Sciences, which is behind brands Cologuard and Oncotype DX, said it will combine CancerSEEK with its scientific platform, clinical organization, and commercial infrastructure. The company ...